These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27074566)

  • 1. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
    DeLoughery E; Avery B; DeLoughery TG
    Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage.
    DeLoughery EP; DeLoughery TG
    Blood Coagul Fibrinolysis; 2017 Dec; 28(8):612-616. PubMed ID: 28654426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
    Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
    Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.
    Pinner NA; Hurdle AC; Oliphant C; Reaves A; Lobo B; Sills A
    World Neurosurg; 2010 Dec; 74(6):631-5. PubMed ID: 21492631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.
    Nishijima DK; Dager WE; Schrot RJ; Holmes JF
    Acad Emerg Med; 2010 Mar; 17(3):244-51. PubMed ID: 20370756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
    Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
    Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII for the Management of Bleeding With Cardiac Surgery.
    Katz A; Ahuja T; Arnouk S; Lewis TC; Marsh K; Papadopoulos J; Merchan C
    J Intensive Care Med; 2022 Feb; 37(2):231-239. PubMed ID: 33402016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
    Kuroski JE; Young S
    Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal strategies and outcomes in patients with atrial fibrillation and warfarin-associated intracranial hemorrhage.
    Singer DE; Borowsky LH; Regan S; Lee JW; Zint K; Franca LR; Goldstein JN
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104903. PubMed ID: 32689580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
    Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discussion of "Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa".
    Van Dusen R
    Am J Surg; 2018 May; 215(5):780-781. PubMed ID: 29366484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.
    Sørensen B; Johansen P; Nielsen GL; Sørensen JC; Ingerslev J
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):469-77. PubMed ID: 12851533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
    Mehringer SL; Klick Z; Bain J; McNeely EB; Subramanian S; Pass LJ; Drinkwater D; Reddy VS
    Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Low Dose Recombinant Factor VIIa and 4-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Cardiac Surgery.
    Caldwell L; Bhakta R; Naik N; Knowles BD; Parker J; Van Berkel Patel M
    J Pharm Pract; 2024 Oct; 37(5):1149-1156. PubMed ID: 38261533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.